Business Description
Aceragen Inc
NAICS : 325414
SIC : 2836
ISIN : US45168K4058
Compare
Compare
Traded in other countries / regions
V9Z.Germany IPO Date
1996-01-25Description
Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.29 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22 | |||||
| 3-Year EBITDA Growth Rate | 42.8 | |||||
| 3-Year EPS without NRI Growth Rate | 49.7 | |||||
| 3-Year FCF Growth Rate | 33.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.83 | |||||
| 9-Day RSI | 25.01 | |||||
| 14-Day RSI | 26.28 | |||||
| 6-1 Month Momentum % | -81 | |||||
| 12-1 Month Momentum % | -90.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.32 | |||||
| Quick Ratio | 0.32 | |||||
| Cash Ratio | 0.12 | |||||
| Days Sales Outstanding | 141.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.9 | |||||
| Shareholder Yield % | 1.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -314.58 | |||||
| Net Margin % | -561.63 | |||||
| FCF Margin % | -406.15 | |||||
| ROE % | -158.48 | |||||
| ROA % | -59.48 | |||||
| ROIC % | -39.06 | |||||
| ROC (Joel Greenblatt) % | -3909.64 | |||||
| ROCE % | -42.2 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.22 | |||||
| PB Ratio | 0.14 | |||||
| EV-to-EBIT | -0.06 | |||||
| EV-to-EBITDA | -0.06 | |||||
| EV-to-Revenue | 0.2 | |||||
| EV-to-FCF | -0.05 | |||||
| Earnings Yield (Greenblatt) % | -1666.67 | |||||
| FCF Yield % | -980.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Aceragen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.332 | ||
| EPS (TTM) ($) | -8.757 | ||
| Beta | 0 | ||
| Volatility % | 83.9 | ||
| 14-Day RSI | 26.28 | ||
| 14-Day ATR ($) | 0.057756 | ||
| 20-Day SMA ($) | 0.41825 | ||
| 12-1 Month Momentum % | -90.4 | ||
| 52-Week Range ($) | 0.3601 - 16 | ||
| Shares Outstanding (Mil) | 8.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aceragen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aceragen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aceragen Inc Frequently Asked Questions
What is Aceragen Inc(ACGN)'s stock price today?
The current price of ACGN is $0.38. The 52 week high of ACGN is $16.00 and 52 week low is $0.36.
When is next earnings date of Aceragen Inc(ACGN)?
The next earnings date of Aceragen Inc(ACGN) is .
Does Aceragen Inc(ACGN) pay dividends? If so, how much?
Aceragen Inc(ACGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers